Riskpilot← Back to searchSign inGet full accessZylinakliniken AB
ABActiveOrg 5593309247Lantmannagatan 9Beauty care and other beauty treatment activities · NACE 9622Est. 20217 employees
Revenue 2024
SEK 5,3M
-6% vs 2023
EBITDA margin
-0.7%
-119% vs 2023
Equity ratio
7.4%
Financial strength
Net profit 2024
SEK -76K
-169% vs 2023
| Revenue | SEK 5,3M | -6% |
| EBITDA | SEK -37K | -119% |
| Net profit | SEK -76K | -169% |
| Total assets | SEK 734K | -23% |
| Equity | SEK 54K | -58% |
| Employees | 7 | — |
Legal name
Zylinakliniken AB
Org number
5593309247
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
18 augusti 2021
Share capital
SEK 25 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva verksamhet inom skönhet med inriktning på estetiska injektionsbehandlingar samt därmed förenlig verksamhet.
Address
Lantmannagatan 9
Email
zultan.z@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 4 807 | 5 624 | 5 311 |
| Staff expenses | −2 279 | −2 609 | −2 646 |
| EBITDA | −80 | 196 | −37 |
| Depreciation & amort. | −18 | −20 | −20 |
| EBIT | −98 | 175 | −58 |
| Net financials | −16 | −30 | −30 |
| Profit before tax | −114 | 146 | −87 |
| Tax | — | −36 | 11 |
| Net profit | −114 | 109 | −76 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 363 | 959 | 734 |
| Equity | 21 | 130 | 54 |
| Long-term debt | 339 | 237 | 136 |
| Short-term debt | 1 003 | 591 | 544 |
| Total debt | 1 342 | 828 | 680 |
EBITDA margin
-0.7%
This company
15.8%
Market median
-104% vs market
20222024
Equity ratio
7.4%
This company
38.2%
Market median
-81% vs market
20222024
Return on equity
-139.7%
This company
18.4%
Market median
-859% vs market
20222024
Net profit margin
-1.4%
This company
8.1%
Market median
-117% vs market
20222024
Asset turnover
7.23×
This company
1.12×
Market median
+546% vs market
20222024
Debt / equity
12.51×
This company
0.62×
Market median
-1918% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Zylinah AB
Zylinakliniken AB Board members of Zylinakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oscar Erik Wilhelm Silfversparre | Audit | 0 companies |
| Zehraa Pauline Sultan | Chairman | 0 companies |
| Carima Rima Chamoun | Chairman | 0 companies |
| Zeinab Mohammed Sultan | Board of Directors | 0 companies |
| Dua Majid Kadum | Deputy Board Member | 0 companies |